Juvenmercsun Pharma Private Limited - Company Profile

It is a pharma private limited company based in Udham Singh Nagar, Uttarakhand, India, established in 2016.
2016 Udham Singh Nagar, Uttarakhand, India Active
Last Updated:
About Juvenmercsun Pharma Private Limited

Juvenmercsun Pharma Private Limited, a active private limited company, was established on 20 January 2016 in Udham Singh Nagar, Uttarakhand, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U85100UR2016PTC001878. Registered under ROC Roc Uttarakhand. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.60 M.

It upholds a active non-compliant status. Its leadership includes Sanjay Kumar Keshari (Director), Bipin Kumar Jha (Director). Past directors included Amit Kumar Singh. It is based at Amardev Nagar, Rudrapur,, Udham Singh Nagar, Uttarakhand, 263153.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85100UR2016PTC001878

  • Registration Number

    001878

  • Incorporation Date

    20 January 2016

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.60 M

  • ROC Code

    Roc Uttarakhand

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.60 M
  • Company Age 10 Year, 23 Days
Company report

Juvenmercsun Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Juvenmercsun Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Juvenmercsun Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Sanjay Kumar Keshari Director 20 Jan 2016 Current
Bipin Kumar Jha Director 20 Jan 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 09 Sep 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Juvenmercsun Pharma.

Enhance accessibility to Juvenmercsun Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Juvenmercsun Pharma revenue growth over time
Juvenmercsun Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Juvenmercsun Pharma?

Unlock access to Juvenmercsun Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Juvenmercsun Pharma?

Unlock and access historical data on people associated with Juvenmercsun Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Juvenmercsun Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Juvenmercsun Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Juvenmercsun Pharma
Recent Activity within the Organization
  • Director Appointment

    The activity Sanjay Kumar Keshari was appointed as a Director was appointed as a Director on 20 Jan 2016 & has been associated with this company since 10 years 23 days . was completed.

  • Director Appointment

    Progress on Bipin Kumar Jha was appointed as a Director was appointed as a Director on 20 Jan 2016 & has been associated with this company since 10 years 23 days . was documented.

  • Company Incorporation

    The activity Juvenmercsun Pharma Private Limited was registered on 20 Jan 2016 with Roc Uttarakhand & aged 10 years 23 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Juvenmercsun Pharma Private Limited?

The CIN of Juvenmercsun Pharma Private Limited is U85100UR2016PTC001878.

Where is Juvenmercsun Pharma Private Limited headquartered?

Juvenmercsun Pharma Private Limited is headquartered at Amardev Nagar, Rudrapur,, Udham Singh Nagar, Uttarakhand, 263153.

When was Juvenmercsun Pharma Private Limited incorporated?

Juvenmercsun Pharma Private Limited was incorporated on 20 January 2016.

Who are the current directors of Juvenmercsun Pharma Private Limited?

The current directors of Juvenmercsun Pharma Private Limited are

What is the primary industry of Juvenmercsun Pharma Private Limited?

The primary industry of Juvenmercsun Pharma Private Limited is Pharma.

Is Juvenmercsun Pharma Private Limited a listed company?

Juvenmercsun Pharma Private Limited is unlisted.

What is the capital structure of Juvenmercsun Pharma Private Limited?

The authorized capital of Juvenmercsun Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.60 M.

What is the compliance status of Juvenmercsun Pharma Private Limited?

The compliance status of Juvenmercsun Pharma Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available